Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/oxford-university-press/pheochromocytoma-paraganglioma-screening-low-rates-in-at-risk-CIqWZjH273
References (8)
-
M Fassnacht, W Arlt, I Bancos (2016)
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors, 175
-
A Hung, S Ahmed, A Gupta (2021)
Performance of the aldosterone to renin ratio as a screening test for primary aldosteronism, 106
-
G Jaffe, Z Gray, G Krishnan (2020)
Screening rates for primary aldosteronism in resistant hypertension: a cohort study, 75
-
AF Turcu, W Nhan, S Grigoryan (2022)
Primary aldosteronism screening rates differ with sex, race, and comorbidities, 11
-
JWM Lenders, MN Kerstens, L Amar (2020)
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension, 38
-
S Grigoryan, W Nhan, L Zhang, C Urban, L Zhao, AF Turcu (2023)
Rates of pheochromocytoma/paraganglioma screening in at-risk populations, 108
-
L Canu, JAW Van Hemert, MN Kerstens (2019)
CT characteristics of pheochromocytoma: relevance for the evaluation of adrenal incidentaloma, 104
-
J Dinnes, I Bancos, L Ferrante di Ruffano (2016)
MANAGEMENT OF ENDOCRINE DISEASE: imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis, 175
- Publisher
- Oxford University Press
- Copyright
- © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: [email protected]
- ISSN
- 0021-972X
- eISSN
- 1945-7197
- DOI
- 10.1210/clinem/dgad029
- Publisher site
- See Article on Publisher Site
Abstract
pheochromocytoma/paraganglioma, screening, secondary hypertension, treatment resistant hypertension, early onset hypertension, adrenal mass Accepted manuscripts Accepted manuscripts are PDF versions of the author’s final manuscript, as accepted for publication by the journal but prior to copyediting or typesetting. They can be cited using the author(s), article title, journal title, year of online publication, and DOI. They will be replaced by the final typeset articles, which may therefore contain changes. The DOI will remain the same throughout. Article PDF first page preview Close PDF This content is only available as a PDF. © The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: [email protected] This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
Journal
The Journal of Clinical Endocrinology & Metabolism – Oxford University Press
Published: Jan 18, 2023
Keywords: pheochromocytoma/paraganglioma; screening; secondary hypertension; treatment resistant hypertension; early onset hypertension; adrenal mass